Anwen Liu
- Topics
- Peptidase Inhibition and Analysis (3 papers)Microtubule and mitosis dynamics (2 papers)MicroRNA in disease regulation (2 papers)
- Journals
- Journal of Clinical OncologyClinical Cancer ResearchBiochemical and Biophysical Research Communications
- Partner nations
- ChinaUnited States
In The Last Decade
Anwen Liu
25 papers receiving 540 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 276
- Cancer Research 135
- Oncology 104
- Pulmonary and Respiratory Medicine 97
- Immunology 75
Countries citing papers authored by Anwen Liu
This map shows the geographic impact of Anwen Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anwen Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anwen Liu more than expected).
Fields of papers citing papers by Anwen Liu
This network shows the impact of papers produced by Anwen Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anwen Liu. The network helps show where Anwen Liu may publish in the future.
Co-authorship network of co-authors of Anwen Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Anwen Liu. A scholar is included among the top collaborators of Anwen Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anwen Liu. Anwen Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 19 | |
| 6 | 7 | |
| 7 | 50 | |
| 8 | 58 | |
| 9 | 10 | |
| 10 | 20 | |
| 11 | 26 | |
| 12 | 23 | |
| 13 | 72 | |
| 14 | 26 | |
| 15 | 3-cinnamoyl-4-hydroxy-6-methyl-2H-pyran-2-one (CHP) inhibits human ovarian cell proliferation by inducing apoptosis. | 8 |
| 16 | 27 | |
| 17 | 4 | |
| 18 | 87 | |
| 19 | 63 | |
| 20 | Shanghai Jiao Tong University participation in high-level feature extraction, automatic search and surveillance event detectionat TRECVID 2008. | 1 |
About Anwen Liu
Anwen Liu is a scholar working on Toxicology, Oncology and Cell Biology, having authored 26 papers that have together received 550 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Microtubule and mitosis dynamics (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (135 citations), Pharmaceutical Science (45 citations) and Radiation (43 citations). Anwen Liu has collaborated with scholars based in China and United States. Frequent co-authors include Jing Cai, Shuhui Zhang, Ao Shen, Hua Nian, Ming-hua Zhu, Tinghui Jiang, Ling Tang, Pamela K. Allen, Daniel R. Gomez and David R. Grosshans. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.